Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-administered Lidocaine Gel for Pain-control During Cervical Preparation
NCT02852434Phase 3Completed
- Sponsor
- Stanford University
- Start
- Jul 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in procedural pain, sponsored by Stanford University. Started Jul 2016; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02852434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02852434.